FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource CodeSystem/FHIR Server from package hl7.eu.fhir.pcsp#current (94 ms)

Package hl7.eu.fhir.pcsp
Type CodeSystem
Id Id
FHIR Version R4
Source http://hl7.eu/fhir/ig/pcsp/https://build.fhir.org/ig/hl7-eu/pcsp/CodeSystem-cs-riskcondition-eu-pcsp.html
Url http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp
Version 0.2.0
Status draft
Date 2024-09-11T13:25:13+00:00
Name CsRiskConditionPcsp
Title PCSP Conditions at risk
Experimental False
Realm eu
Authority hl7
Description Condition at risk proposed by the PCSP algorithm
Content complete

Resources that use this resource

ValueSet
vs-riskcondition-eu-pcsp Conditions at risk

Resources that this resource uses

No resources found



Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: CodeSystem cs-riskcondition-eu-pcsp

This case-sensitive code system http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp defines the following codes:

CodeDisplayDefinition
1 Subsequent thyroid cancerSubsequent thyroid cancer
2 Subsequent breast cancerSubsequent breast cancer
3 Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
4 Impaired fertility Impaired spermatogenesisImpaired fertility Impaired spermatogenesis
5 Testosterone deficiencyTestosterone deficiency
6 Physical sexual dysfunctionPhysical sexual dysfunction
7 Premature ovarian insufficiencyPremature ovarian insufficiency
8 Ear problemsEar problems
9 Impaired glucose metabolism and diabetes melitusImpaired glucose metabolism and diabetes melitus
10 DyslipidemiaDyslipidemia
11 Overweight and obesityOverweight and obesity
12 HypertensionHypertension
13 Reduced bone mineral densityReduced bone mineral density
14 OsteonecrosisOsteonecrosis
15 Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
16 Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)
17 Central precocious puberty (CPP) For girls with age below 8 yearsCentral precocious puberty (CPP) For girls with age below 8 years
18 Central precocious puberty (CPP) For boys with age below 9 yearssCentral precocious puberty (CPP) For boys with age below 9 yearss
19 Thyroid function problemsThyroid function problems
20 Cerebrovascular problemCerebrovascular problem
21 Neurocognitive problemsNeurocognitive problems
22 Peripheral neuropathyPeripheral neuropathy
23 CataractCataract
24 Eye problemsEye problems
25 Craniofacial growth problemsCraniofacial growth problems
26 Spine scoliosis and kyphosisSpine scoliosis and kyphosis
27 Lower urinary tract problemsLower urinary tract problems
28 Obstetric problemsObstetric problems
29 Dental and oral problemsDental and oral problems
30 Gastro-intestinal problemsGastro-intestinal problems
31 ArrhythmiaArrhythmia
32 Pulmonary problemsPulmonary problems
33 Renal problems (Glomerular dysfunction - Tubular dysfunction)Renal problems (Glomerular dysfunction - Tubular dysfunction)
34 Liver problemsLiver problems
35 Iron overloadIron overload
36 Spleen problemsSpleen problems
37 Tumor predispositionTumor predisposition
38 Subsequent melanoma and non-melanoma skin cancerSubsequent melanoma and non-melanoma skin cancer
39 Subsequent colorectal cancerSubsequent colorectal cancer
40 Subsequent Oral CancerSubsequent Oral Cancer
41 Subsequent acute myeloid leukaemia or myelodysplasiaSubsequent acute myeloid leukaemia or myelodysplasia
42 Subsequent bladder cancerSubsequent bladder cancer
43 Subsequent Bone CancerSubsequent Bone Cancer
44 Subsequent lung cancerSubsequent lung cancer
45 Subsequent CNS neoplasmsSubsequent CNS neoplasms
46 Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)
47 Renal problems (Tubular dysfunction)Renal problems (Tubular dysfunction)

Source

{
  "resourceType" : "CodeSystem",
  "id" : "cs-riskcondition-eu-pcsp",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem cs-riskcondition-eu-pcsp</b></p><a name=\"cs-riskcondition-eu-pcsp\"> </a><a name=\"hccs-riskcondition-eu-pcsp\"> </a><a name=\"cs-riskcondition-eu-pcsp-en-US\"> </a><p>This case-sensitive code system <code>http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">1<a name=\"cs-riskcondition-eu-pcsp-1\"> </a></td><td>Subsequent thyroid cancer</td><td>Subsequent thyroid cancer</td></tr><tr><td style=\"white-space:nowrap\">2<a name=\"cs-riskcondition-eu-pcsp-2\"> </a></td><td>Subsequent breast cancer</td><td>Subsequent breast cancer</td></tr><tr><td style=\"white-space:nowrap\">3<a name=\"cs-riskcondition-eu-pcsp-3\"> </a></td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td></tr><tr><td style=\"white-space:nowrap\">4<a name=\"cs-riskcondition-eu-pcsp-4\"> </a></td><td>Impaired fertility Impaired spermatogenesis</td><td>Impaired fertility Impaired spermatogenesis</td></tr><tr><td style=\"white-space:nowrap\">5<a name=\"cs-riskcondition-eu-pcsp-5\"> </a></td><td>Testosterone deficiency</td><td>Testosterone deficiency</td></tr><tr><td style=\"white-space:nowrap\">6<a name=\"cs-riskcondition-eu-pcsp-6\"> </a></td><td>Physical sexual dysfunction</td><td>Physical sexual dysfunction</td></tr><tr><td style=\"white-space:nowrap\">7<a name=\"cs-riskcondition-eu-pcsp-7\"> </a></td><td>Premature ovarian insufficiency</td><td>Premature ovarian insufficiency</td></tr><tr><td style=\"white-space:nowrap\">8<a name=\"cs-riskcondition-eu-pcsp-8\"> </a></td><td>Ear problems</td><td>Ear problems</td></tr><tr><td style=\"white-space:nowrap\">9<a name=\"cs-riskcondition-eu-pcsp-9\"> </a></td><td>Impaired glucose metabolism and diabetes melitus</td><td>Impaired glucose metabolism and diabetes melitus</td></tr><tr><td style=\"white-space:nowrap\">10<a name=\"cs-riskcondition-eu-pcsp-10\"> </a></td><td>Dyslipidemia</td><td>Dyslipidemia</td></tr><tr><td style=\"white-space:nowrap\">11<a name=\"cs-riskcondition-eu-pcsp-11\"> </a></td><td>Overweight and obesity</td><td>Overweight and obesity</td></tr><tr><td style=\"white-space:nowrap\">12<a name=\"cs-riskcondition-eu-pcsp-12\"> </a></td><td>Hypertension</td><td>Hypertension</td></tr><tr><td style=\"white-space:nowrap\">13<a name=\"cs-riskcondition-eu-pcsp-13\"> </a></td><td>Reduced bone mineral density</td><td>Reduced bone mineral density</td></tr><tr><td style=\"white-space:nowrap\">14<a name=\"cs-riskcondition-eu-pcsp-14\"> </a></td><td>Osteonecrosis</td><td>Osteonecrosis</td></tr><tr><td style=\"white-space:nowrap\">15<a name=\"cs-riskcondition-eu-pcsp-15\"> </a></td><td>Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td><td>Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td></tr><tr><td style=\"white-space:nowrap\">16<a name=\"cs-riskcondition-eu-pcsp-16\"> </a></td><td>Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td><td>Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)</td></tr><tr><td style=\"white-space:nowrap\">17<a name=\"cs-riskcondition-eu-pcsp-17\"> </a></td><td>Central precocious puberty (CPP) For girls with age below 8 years</td><td>Central precocious puberty (CPP) For girls with age below 8 years</td></tr><tr><td style=\"white-space:nowrap\">18<a name=\"cs-riskcondition-eu-pcsp-18\"> </a></td><td>Central precocious puberty (CPP) For boys with age below 9 yearss</td><td>Central precocious puberty (CPP) For boys with age below 9 yearss</td></tr><tr><td style=\"white-space:nowrap\">19<a name=\"cs-riskcondition-eu-pcsp-19\"> </a></td><td>Thyroid function problems</td><td>Thyroid function problems</td></tr><tr><td style=\"white-space:nowrap\">20<a name=\"cs-riskcondition-eu-pcsp-20\"> </a></td><td>Cerebrovascular problem</td><td>Cerebrovascular problem</td></tr><tr><td style=\"white-space:nowrap\">21<a name=\"cs-riskcondition-eu-pcsp-21\"> </a></td><td>Neurocognitive problems</td><td>Neurocognitive problems</td></tr><tr><td style=\"white-space:nowrap\">22<a name=\"cs-riskcondition-eu-pcsp-22\"> </a></td><td>Peripheral neuropathy</td><td>Peripheral neuropathy</td></tr><tr><td style=\"white-space:nowrap\">23<a name=\"cs-riskcondition-eu-pcsp-23\"> </a></td><td>Cataract</td><td>Cataract</td></tr><tr><td style=\"white-space:nowrap\">24<a name=\"cs-riskcondition-eu-pcsp-24\"> </a></td><td>Eye problems</td><td>Eye problems</td></tr><tr><td style=\"white-space:nowrap\">25<a name=\"cs-riskcondition-eu-pcsp-25\"> </a></td><td>Craniofacial growth problems</td><td>Craniofacial growth problems</td></tr><tr><td style=\"white-space:nowrap\">26<a name=\"cs-riskcondition-eu-pcsp-26\"> </a></td><td>Spine scoliosis and kyphosis</td><td>Spine scoliosis and kyphosis</td></tr><tr><td style=\"white-space:nowrap\">27<a name=\"cs-riskcondition-eu-pcsp-27\"> </a></td><td>Lower urinary tract problems</td><td>Lower urinary tract problems</td></tr><tr><td style=\"white-space:nowrap\">28<a name=\"cs-riskcondition-eu-pcsp-28\"> </a></td><td>Obstetric problems</td><td>Obstetric problems</td></tr><tr><td style=\"white-space:nowrap\">29<a name=\"cs-riskcondition-eu-pcsp-29\"> </a></td><td>Dental and oral problems</td><td>Dental and oral problems</td></tr><tr><td style=\"white-space:nowrap\">30<a name=\"cs-riskcondition-eu-pcsp-30\"> </a></td><td>Gastro-intestinal problems</td><td>Gastro-intestinal problems</td></tr><tr><td style=\"white-space:nowrap\">31<a name=\"cs-riskcondition-eu-pcsp-31\"> </a></td><td>Arrhythmia</td><td>Arrhythmia</td></tr><tr><td style=\"white-space:nowrap\">32<a name=\"cs-riskcondition-eu-pcsp-32\"> </a></td><td>Pulmonary problems</td><td>Pulmonary problems</td></tr><tr><td style=\"white-space:nowrap\">33<a name=\"cs-riskcondition-eu-pcsp-33\"> </a></td><td>Renal problems (Glomerular dysfunction - Tubular dysfunction)</td><td>Renal problems (Glomerular dysfunction - Tubular dysfunction)</td></tr><tr><td style=\"white-space:nowrap\">34<a name=\"cs-riskcondition-eu-pcsp-34\"> </a></td><td>Liver problems</td><td>Liver problems</td></tr><tr><td style=\"white-space:nowrap\">35<a name=\"cs-riskcondition-eu-pcsp-35\"> </a></td><td>Iron overload</td><td>Iron overload</td></tr><tr><td style=\"white-space:nowrap\">36<a name=\"cs-riskcondition-eu-pcsp-36\"> </a></td><td>Spleen problems</td><td>Spleen problems</td></tr><tr><td style=\"white-space:nowrap\">37<a name=\"cs-riskcondition-eu-pcsp-37\"> </a></td><td>Tumor predisposition</td><td>Tumor predisposition</td></tr><tr><td style=\"white-space:nowrap\">38<a name=\"cs-riskcondition-eu-pcsp-38\"> </a></td><td>Subsequent melanoma and non-melanoma skin cancer</td><td>Subsequent melanoma and non-melanoma skin cancer</td></tr><tr><td style=\"white-space:nowrap\">39<a name=\"cs-riskcondition-eu-pcsp-39\"> </a></td><td>Subsequent colorectal cancer</td><td>Subsequent colorectal cancer</td></tr><tr><td style=\"white-space:nowrap\">40<a name=\"cs-riskcondition-eu-pcsp-40\"> </a></td><td>Subsequent Oral Cancer</td><td>Subsequent Oral Cancer</td></tr><tr><td style=\"white-space:nowrap\">41<a name=\"cs-riskcondition-eu-pcsp-41\"> </a></td><td>Subsequent acute myeloid leukaemia or myelodysplasia</td><td>Subsequent acute myeloid leukaemia or myelodysplasia</td></tr><tr><td style=\"white-space:nowrap\">42<a name=\"cs-riskcondition-eu-pcsp-42\"> </a></td><td>Subsequent bladder cancer</td><td>Subsequent bladder cancer</td></tr><tr><td style=\"white-space:nowrap\">43<a name=\"cs-riskcondition-eu-pcsp-43\"> </a></td><td>Subsequent Bone Cancer</td><td>Subsequent Bone Cancer</td></tr><tr><td style=\"white-space:nowrap\">44<a name=\"cs-riskcondition-eu-pcsp-44\"> </a></td><td>Subsequent lung cancer</td><td>Subsequent lung cancer</td></tr><tr><td style=\"white-space:nowrap\">45<a name=\"cs-riskcondition-eu-pcsp-45\"> </a></td><td>Subsequent CNS neoplasms</td><td>Subsequent CNS neoplasms</td></tr><tr><td style=\"white-space:nowrap\">46<a name=\"cs-riskcondition-eu-pcsp-46\"> </a></td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td><td>Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)</td></tr><tr><td style=\"white-space:nowrap\">47<a name=\"cs-riskcondition-eu-pcsp-47\"> </a></td><td>Renal problems (Tubular dysfunction)</td><td>Renal problems (Tubular dysfunction)</td></tr></table></div>"
  },
  "url" : "http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp",
  "version" : "0.2.0",
  "name" : "CsRiskConditionPcsp",
  "title" : "PCSP Conditions at risk",
  "status" : "draft",
  "experimental" : false,
  "date" : "2024-09-11T13:25:13+00:00",
  "publisher" : "PanCareSurPass Project",
  "contact" : [
    {
      "name" : "PanCareSurPass Project",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://www.pancaresurpass.eu/"
        }
      ]
    },
    {
      "name" : "PanCareSurPass Project",
      "telecom" : [
        {
          "system" : "url",
          "value" : "https://www.pancaresurpass.eu/"
        }
      ]
    }
  ],
  "description" : "Condition at risk proposed by the PCSP algorithm",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "150",
          "display" : "Europe"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 47,
  "concept" : [
    {
      "code" : "1",
      "display" : "Subsequent thyroid cancer",
      "definition" : "Subsequent thyroid cancer"
    },
    {
      "code" : "2",
      "display" : "Subsequent breast cancer",
      "definition" : "Subsequent breast cancer"
    },
    {
      "code" : "3",
      "display" : "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)",
      "definition" : "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)"
    },
    {
      "code" : "4",
      "display" : "Impaired fertility Impaired spermatogenesis",
      "definition" : "Impaired fertility Impaired spermatogenesis"
    },
    {
      "code" : "5",
      "display" : "Testosterone deficiency",
      "definition" : "Testosterone deficiency"
    },
    {
      "code" : "6",
      "display" : "Physical sexual dysfunction",
      "definition" : "Physical sexual dysfunction"
    },
    {
      "code" : "7",
      "display" : "Premature ovarian insufficiency",
      "definition" : "Premature ovarian insufficiency"
    },
    {
      "code" : "8",
      "display" : "Ear problems",
      "definition" : "Ear problems"
    },
    {
      "code" : "9",
      "display" : "Impaired glucose metabolism and diabetes melitus",
      "definition" : "Impaired glucose metabolism and diabetes melitus"
    },
    {
      "code" : "10",
      "display" : "Dyslipidemia",
      "definition" : "Dyslipidemia"
    },
    {
      "code" : "11",
      "display" : "Overweight and obesity",
      "definition" : "Overweight and obesity"
    },
    {
      "code" : "12",
      "display" : "Hypertension",
      "definition" : "Hypertension"
    },
    {
      "code" : "13",
      "display" : "Reduced bone mineral density",
      "definition" : "Reduced bone mineral density"
    },
    {
      "code" : "14",
      "display" : "Osteonecrosis",
      "definition" : "Osteonecrosis"
    },
    {
      "code" : "15",
      "display" : "Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)",
      "definition" : "Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)"
    },
    {
      "code" : "16",
      "display" : "Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)",
      "definition" : "Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD)"
    },
    {
      "code" : "17",
      "display" : "Central precocious puberty (CPP) For girls with age below 8 years",
      "definition" : "Central precocious puberty (CPP) For girls with age below 8 years"
    },
    {
      "code" : "18",
      "display" : "Central precocious puberty (CPP) For boys with age below 9 yearss",
      "definition" : "Central precocious puberty (CPP) For boys with age below 9 yearss"
    },
    {
      "code" : "19",
      "display" : "Thyroid function problems",
      "definition" : "Thyroid function problems"
    },
    {
      "code" : "20",
      "display" : "Cerebrovascular problem",
      "definition" : "Cerebrovascular problem"
    },
    {
      "code" : "21",
      "display" : "Neurocognitive problems",
      "definition" : "Neurocognitive problems"
    },
    {
      "code" : "22",
      "display" : "Peripheral neuropathy",
      "definition" : "Peripheral neuropathy"
    },
    {
      "code" : "23",
      "display" : "Cataract",
      "definition" : "Cataract"
    },
    {
      "code" : "24",
      "display" : "Eye problems",
      "definition" : "Eye problems"
    },
    {
      "code" : "25",
      "display" : "Craniofacial growth problems",
      "definition" : "Craniofacial growth problems"
    },
    {
      "code" : "26",
      "display" : "Spine scoliosis and kyphosis",
      "definition" : "Spine scoliosis and kyphosis"
    },
    {
      "code" : "27",
      "display" : "Lower urinary tract problems",
      "definition" : "Lower urinary tract problems"
    },
    {
      "code" : "28",
      "display" : "Obstetric problems",
      "definition" : "Obstetric problems"
    },
    {
      "code" : "29",
      "display" : "Dental and oral problems",
      "definition" : "Dental and oral problems"
    },
    {
      "code" : "30",
      "display" : "Gastro-intestinal problems",
      "definition" : "Gastro-intestinal problems"
    },
    {
      "code" : "31",
      "display" : "Arrhythmia",
      "definition" : "Arrhythmia"
    },
    {
      "code" : "32",
      "display" : "Pulmonary problems",
      "definition" : "Pulmonary problems"
    },
    {
      "code" : "33",
      "display" : "Renal problems (Glomerular dysfunction - Tubular dysfunction)",
      "definition" : "Renal problems (Glomerular dysfunction - Tubular dysfunction)"
    },
    {
      "code" : "34",
      "display" : "Liver problems",
      "definition" : "Liver problems"
    },
    {
      "code" : "35",
      "display" : "Iron overload",
      "definition" : "Iron overload"
    },
    {
      "code" : "36",
      "display" : "Spleen problems",
      "definition" : "Spleen problems"
    },
    {
      "code" : "37",
      "display" : "Tumor predisposition",
      "definition" : "Tumor predisposition"
    },
    {
      "code" : "38",
      "display" : "Subsequent melanoma and non-melanoma skin cancer",
      "definition" : "Subsequent melanoma and non-melanoma skin cancer"
    },
    {
      "code" : "39",
      "display" : "Subsequent colorectal cancer",
      "definition" : "Subsequent colorectal cancer"
    },
    {
      "code" : "40",
      "display" : "Subsequent Oral Cancer",
      "definition" : "Subsequent Oral Cancer"
    },
    {
      "code" : "41",
      "display" : "Subsequent acute myeloid leukaemia or myelodysplasia",
      "definition" : "Subsequent acute myeloid leukaemia or myelodysplasia"
    },
    {
      "code" : "42",
      "display" : "Subsequent bladder cancer",
      "definition" : "Subsequent bladder cancer"
    },
    {
      "code" : "43",
      "display" : "Subsequent Bone Cancer",
      "definition" : "Subsequent Bone Cancer"
    },
    {
      "code" : "44",
      "display" : "Subsequent lung cancer",
      "definition" : "Subsequent lung cancer"
    },
    {
      "code" : "45",
      "display" : "Subsequent CNS neoplasms",
      "definition" : "Subsequent CNS neoplasms"
    },
    {
      "code" : "46",
      "display" : "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)",
      "definition" : "Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia)"
    },
    {
      "code" : "47",
      "display" : "Renal problems (Tubular dysfunction)",
      "definition" : "Renal problems (Tubular dysfunction)"
    }
  ]
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.